Clene Nanomedicine
Clinical trials sponsored by Clene Nanomedicine, explained in plain language.
-
Experimental MS treatment offered to select patients
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides early access to an experimental oral treatment called CNM-Au8 for up to 25 people with multiple sclerosis. Participants will take the medication daily for 96 weeks while doctors monitor their safety and how well the treatment works. The program is designed f…
Sponsor: Clene Nanomedicine • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
ALS patients get extended access to experimental treatment in Follow-Up study
Disease control OngoingThis study offers extended treatment with CNM-Au8 to patients with early ALS who completed the initial trial. The goal is to continue assessing whether this experimental treatment can slow disease progression while monitoring safety. Participants receive the active treatment for …
Phase: PHASE2 • Sponsor: Clene Nanomedicine • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC